Does IPTACOPAN Cause Product dose omission issue? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Product dose omission issue have been filed in association with IPTACOPAN (FABHALTA). This represents 4.9% of all adverse event reports for IPTACOPAN.
23
Reports of Product dose omission issue with IPTACOPAN
4.9%
of all IPTACOPAN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product dose omission issue From IPTACOPAN?
Of the 23 reports, 5 (21.7%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPTACOPAN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does IPTACOPAN Cause?
Headache (63)
Fatigue (45)
Diarrhoea (32)
Nausea (32)
Haemoglobin decreased (31)
Pyrexia (25)
Breakthrough haemolysis (22)
Rash (22)
Drug ineffective (21)
Off label use (20)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which IPTACOPAN Alternatives Have Lower Product dose omission issue Risk?
IPTACOPAN vs IRBESARTAN
IPTACOPAN vs IRINOTECAN
IPTACOPAN vs IRON
IPTACOPAN vs IRON DEXTRAN
IPTACOPAN vs IRON ISOMALTOSIDE 1000